Global Fingolimod Market, Size, Share, Analysis Report & Forecast to 2026

The global fingolimod market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing prevalence of multiple sclerosis disease. According to Atlas of MS, there are around 2.8 million people worldwide who are suffering from multiple sclerosis. This factor will fuel the demand of the market during the forecast period as fingolimod is used for the treatment of multiple sclerosis.

Free Sample Copy @ https://www.omrglobal.com/request-sample/fingolimod-market

Fingolimod is an immunomodulation medication that is sold under the name of Gilenya. The drug was developed by Novartis and got approved by US FDA in 2010. The drug prevents immune system cells or also called lymphocytes from attacking the nerves present in your brain and spinal cord which can further prevent or delay the episodes which patients suffer, thus this major factor can lead to growing demand during the forecast period.

A Full Report of Global Fingolimod Market is Available at:
https://www.omrglobal.com/industry-reports/fingolimod-market

Recently, in June 2021, Dr Reddy’s Laboratories got the US FDA approval to market the Fingolimod capsules which will be having a strength of 0.25 mg. The drug will be manufacture in the Ahmedabad factory of the company. Some of the key global players in the global fingolimod market include Novartis AG, AstraZeneca, Dr Reddy’s Laboratories, and many others.

Global Fingolimod Market – Segmentation
By Type
Oral
Injection
By Application
Medical field
Science Research field
Hospitals
Others

Global Fingolimod Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Novartis AG
AstraZeneca
Dr Reddy’s Laboratories

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fingolimod-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

Leave a comment

Your email address will not be published. Required fields are marked *